Arkolith/Insider Trading/MLYS/Form 4

Karydas Daphne

DirectorMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Apr 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$75K
Net Open-Market Flow
-$75K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2026Option exercise(M)3K$12.02$36K9K
Mar 31, 2026Sell(S)3K$25.00$75K6K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 31, 2026Option exercise(M)3K—$041K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001816952-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML